Overview
Study information
| Network: | CAVD |
| Grant Affiliation: | Barouch: Therapeutic Efficacy of Potent Broadly Neutralizing mAbs for HIV-1 Eradication |
| Strategy: | Prophylactic neutralizing Ab |
| Study Type: | Antibody Screening |
| Species: | Non-Organism Study |
| Stage: | In Progress |
| Study Start Date: | 2016-03-15 |
| Study Made Public: | NA |
Title
To compare the spectrum of neutralizing activity by three candidate clinical clones of PGDM1400
Description
CAVD 554 is an immunogenicity study to characterize new PGDM1400 clone antibodies.
Sign in to see full information about this study and to download study data.
Products
No Products used in studyIntegrated data
NAb MAb
Non-integrated data
No non-integrated data is available for this study.